Kamada Ltd(NASDAQ:KMDA) 
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to congenital Al...
Website: http://www.kamada.com
Founded: 1990
Full Time Employees: 429
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.08
H 6.13
L 5.79
C 5.99
V 191,338
10EMA 5.99
20EMA 5.99
60EMA 5.99
120EMA 5.99
250EMA 5.99